We are live on ! Find out more
CBIO

Crescent Biopharma

55 hedge funds and large institutions have $61.9M invested in Crescent Biopharma in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more call options, than puts

Call options by funds: $247K | Put options by funds: $120K

33% more capital invested

Capital invested by funds: $46.6M → $61.9M (+$15.3M)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 5455 (+1)

0.02% less ownership

Funds ownership: 0.58%0.55% (-0.02%)

68% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 19

Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
6
Reduced
19
Closed
8
Calls
$247K
Puts
$120K
Net Calls
+$127K
Net Calls Change
+$13K